Who Should Not Take Nootropics: Contraindications and High-Risk Groups
The nootropics market hit $10.6 billion in 2025, with millions chasing sharper focus and better memory. But here’s what the supplement companies won’t tell you upfront: for certain people, these brain-boosting compounds don’t just fail to help—they actively harm. Understanding who should not take nootropics isn’t about fear-mongering. It’s about respecting the reality that optimization…
